
Tune in to industry innovators sharing real experiences – turning digital potential into a competitive advantage and improving patient outcomes. Previously known as Driving Digital in Biopharma.
| Publishes | Infrequently | Episodes | 39 | Founded | 6 years ago |
|---|---|---|---|---|---|
| Number of Listeners | Categories | MedicineLife SciencesScienceHealth & Fitness | |||

Tom Lehmann and Matteo di Tommaso, SVP and Head of Research and Development IT, at Bristol-Myers Squibb, explore approaches to scale AI across drug development, discussing a predict-first mindset to human-led platforms driving real impact on how medi... more
Join Tom Lehmann and Petra Jantzer, Accenture's Global Life Sciences Lead, as they cover the highlights of 2025 and look forward to 2026. What's coming next for biopharma? Tune in for the trends and insights that will shape the future.
Join Roy Helmy, Associate VP at Merck, as he explores what it takes to reinvent the lab from the ground up. From AI to end-to-end digital transformation of lab operations, Roy shares actionable insights on overcoming resistance and fostering collabor... more
In this episode, host Tom Lehmann speaks with Sanjay Patel, Global Head of Innovation Capability Solutions & Services at Takeda, regarding how global collaboration and innovative leadership are reshaping the biotech landscape. Sanjay shares insights ... more
Discover how digital innovation and Gen AI are reshaping pharma with Anvita Karara. Explore how patient-centricity, personalization, and responsible AI are driving better health outcomes and transforming engagement at scale.
An episode with Tracy Ring, Accenture's Chief Data Officer and Global Generative AI Lead for Life Sciences explores how advanced AI, cognitive digital brains, and agentic systems are transforming business efficiency, trust, and customer interactions.... more
A discussion with David Hole, Global Life Sciences T&O lead about how GenAI is transforming the life sciences workforce, emphasizing the need for new skills, ethical considerations, and the balance between democratization and governance.
Matt Studney, from Merck's Research Laboratories Information Technology discusses AI's growing role in pharma and the need for responsible implementation to enhance health outcomes.
People also subscribe to these shows.











Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
| Listeners per Episode | |
|---|---|
| Gender Skew | |
| Location | |
| Interests | |
| Professions | |
| Age Range | |
| Household Income | |
| Social Media Reach |
This series focuses on how digital technologies, AI, and data-driven approaches are reshaping life sciences—from research labs to patient care and market strategies. Across episodes, conversations emphasize enabling technologies like generative AI, automation, and data analytics, paired with human-centered design and responsible AI practices. Listeners often hear practical examples of digital transformation in pharma and biotech, including lab modernization, personalized medicine, and better engagement with healthcare providers and patients. The show tends to feature senior perspectives from pharma, biotech, and consulting, with a strong emphasis on turning technology into real-world outcomes, improving efficiency, innovation, and patient e... more
Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with this podcast:
1. SmartLess
this podcast launched 6 years ago and published 39 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on this podcast include:
1. Matteo di Tommaso
2. Roy Helmy
3. Sanjay Patel
4. Anvita Karara
5. David Hole
6. Matt Studney
7. Tracy Ring
8. Christian Fox
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.